BEST UNLIMITED TURBO LONG CERTIFICATE - ROCHE GS Stock

Certificat

7A73S

DE000SU772Y9

Real-time Euronext Paris 09:18:42 2024-05-15 EDT
8.24 EUR +3.13% Intraday chart for BEST UNLIMITED TURBO LONG CERTIFICATE - ROCHE GS
Current month+4.44%
1 month-3.27%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-15 8.24 +3.13%
24-05-14 7.99 -4.08%
24-05-13 8.33 +2.08%
24-05-10 8.16 +2.38%
24-05-09 7.97 +0.89%

Real-time Euronext Paris

Last update May 15, 2024 at 09:18 am

More quotes

Static data

Product typeCertificat Turbo
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Société Générale Société Générale
7A73S
ISINDE000SU772Y9
Date issued 2024-02-12
Strike 146.4 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 7.86
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 10
Lowest since issue 6.99
Spread 0.01
Spread %0.12%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
224.6 CHF
Average target price
279.4 CHF
Spread / Average Target
+24.39%
Consensus
  1. Stock Market
  2. Certificates
  3. 7A73S Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW